Skip to main
SEPN

Septerna Inc (SEPN) Stock Forecast & Price Target

Septerna Inc (SEPN) Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 63%
Buy 38%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Septerna is facing increased risks in running a CSU study without further clarity, but their decision to wait on Ph2b initiation may enable capital-efficient exploration of SEP-631 in a smaller signal-finding study. Their enthusiasm for their oral PTH asset and Native GPCR platform is increased due to physician interest in novel PTH treatments, leading to a potential for significant market share for their asset SEP-479. With conservative assumptions and a discounted cash flow valuation, Septerna's price objective is estimated to be $40/shr with a 30% probability of approval for their lead MRGPRX2 receptor agonist candidate and 15% probability of approval for their TSHR NAM and GLP-1R/GIPR/GCGR agonist candidates.

Bears say

Septerna is facing substantial risks in its drug discovery and pipeline development, with a low probability of success for its oral native platform and a weak forecast for future revenue and earnings due to competition in multiple therapeutic areas. Recent competitor failures have limited direct read-through, but the company's current strategy and focus on targeting mast cell-driven diseases may not be sufficient for overall success in the market. Despite a strong financial position, with over $500M in cash and securities, the company's ongoing net losses and lack of significant service revenue suggest that investments should be made cautiously.

Septerna Inc (SEPN) has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 63% of analysts recommend a Strong Buy, 38% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Septerna Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Septerna Inc (SEPN) Forecast

Analysts have given Septerna Inc (SEPN) a Strong Buy based on their latest research and market trends.

According to 8 analysts, Septerna Inc (SEPN) has a Strong Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $41.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $41.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Septerna Inc (SEPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.